NPI: 1770035214 · MURFREESBORO, TN 37129 · 261QU0200X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,393 | $127K |
| 2019 | 10,057 | $241K |
| 2020 | 12,216 | $248K |
| 2021 | 23,180 | $617K |
| 2022 | 24,337 | $842K |
| 2023 | 31,991 | $995K |
| 2024 | 26,652 | $851K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | 21,701 | 19,621 | $1.28M | |
| 99213 | 18,063 | 16,518 | $726K | |
| 99204 | 5,691 | 5,176 | $521K | |
| 87426 | 12,335 | 11,186 | $373K | |
| 99203 | 5,730 | 5,283 | $356K | |
| 87804 | 18,439 | 8,547 | $181K | |
| 99215 | Prolong outpt/office vis | 1,563 | 1,409 | $119K |
| 96372 | 7,355 | 5,522 | $107K | |
| 87811 | 2,426 | 2,188 | $88K | |
| 87880 | 9,727 | 9,059 | $79K | |
| 71046 | 2,228 | 1,976 | $32K | |
| 99205 | Prolong outpt/office vis | 234 | 202 | $24K |
| 87636 | 112 | 108 | $13K | |
| 81003 | 5,213 | 4,616 | $7K | |
| J1030 | Methylprednisolone 40 mg inj | 840 | 695 | $4K |
| J1040 | Methylprednisolone 80 mg inj | 155 | 128 | $2K |
| J3301 | Triamcinolone acet inj nos | 1,360 | 1,238 | $1K |
| 3008F | 11,741 | 10,020 | $1K | |
| 36415 | 844 | 763 | $1K | |
| 81025 | 274 | 257 | $1K | |
| 73130 | 57 | 54 | $866.62 | |
| J1100 | Dexamethasone sodium phos | 2,639 | 2,339 | $756.72 |
| 87807 | 93 | 93 | $725.80 | |
| 93000 | 42 | 40 | $619.34 | |
| J1885 | Ketorolac tromethamine inj | 922 | 805 | $396.90 |
| 73620 | 32 | 31 | $391.26 | |
| J0696 | Ceftriaxone sodium injection | 536 | 455 | $225.57 |
| 73562 | 12 | 12 | $224.15 | |
| 81001 | 74 | 66 | $101.04 | |
| 99000 | 1,352 | 1,165 | $11.92 | |
| 99072 | 36 | 30 | $0.00 |